Acinar Cell Transdifferentiation via GnT-V Overexpression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack an effective way to promote the stemness and transdifferentiation of acinar cells, particularly for converting salivary gland acinar cells into insulin-secreting cells, and there is a need for a reliable insulin production system to reduce the frequency of insulin administration in diabetic patients.
Innovation Solution
A method involving the transfection of acinar cells with a plasmid containing genetic material for overexpression of N-acetylglucosaminyltransferase V (GnT-V), using techniques like calcium phosphate, liposome, or viral vectors, which enables the cells to transdifferentiate into insulin-secreting cells, thereby promoting stemness and enabling insulin production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If acinar cells are isolated from human parotid gland tissues, then high purity ACs can be obtained, but the amount of ACs is difficult to enrich due to lack of regular supply of salivary gland specimens and loss of replicative ability in vitro
Solution Approach 1:
The patent applies preliminary action by transfecting acinar cells with GnT-V plasmid before culture expansion. This genetic modification is performed in advance to enable the cells to overcome their natural replicative limitations and maintain proliferation capacity during in vitro culture, thus allowing enrichment of ACs without compromising purity
Solution Approach 2:
The patent changes the biochemical parameters of acinar cells by introducing GnT-V enzyme expression through plasmid transfection. This parameter change (addition of specific glycosylation enzyme) fundamentally alters the cells' replicative properties, enabling them to proliferate in vitro while maintaining their differentiated function and high purity
2Productivity
If plasmid transfection is performed using viral vectors, then transfection efficiency is improved, but the complexity of the procedure increases
Solution Approach 1:
The patent uses viral vectors as intermediary carriers to deliver the GnT-V plasmid into acinar cells. The viral vector acts as a mediator that efficiently transports genetic material across the cell membrane, achieving high transfection efficiency while the patent provides optimized protocols to manage the procedural complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method effectively promotes stemness and transdifferentiation of acinar cells, allowing them to produce insulin, which can be harvested for therapeutic use in treating salivary gland damage and providing a novel insulin production system for diabetic patients.
Implementation Method 1
the plasmid is transfected into the acinar cell by calcium phosphate
Implementation Method 2
the plasmid is transfected into the acinar cell by liposome
Implementation Method 3
the plasmid is transfected into the acinar cell by viral vector
Implementation Method 4
the plasmid is transfected into the acinar cell by electroporation
Implementation Method 5
the transfected acinar cell can transdifferentiate into an insulin-secreting cell
Implementation Method 6
the plasmid contains a genetic material for overexpression of N-acetylglucosaminyltransferase V (GnT-V)
Implementation Method 7
enable the parotid gland tissue of diabetic patients to synthesize insulin by itself
Implementation Method 8
a method for producing insulin by using the above method, which further comprises a step of harvesting insulin from the cell culture medium
Data Source
AI summary
The present application provides a method for promoting the sternness and/or transdifferentiation of acinar cells, comprising the following steps: providing an acinar cell, transfecting a plasmid into the acinar cell, and culturing the transfected acinar cell, wherein the plasmid contains a genetic material for overexpression of N-acetylglucosaminyltransferase V (GnT-V).